Company profile: Instylla
1.1 - Company Overview
Company description
- Provider of next-generation liquid embolics for interventional radiology. Offers the Embrace Hydrogel Embolic System (HES), a device that embolizes hypervascular tumors and peripheral arterial bleeds by forming a soft hydrogel to fill vessel lumens during embolization.
Products and services
- Embrace Hydrogel Embolic System (HES): Hydrogel-based device engineered to embolize hypervascular tumors and peripheral arterial bleeds by forming a soft hydrogel that fills vessel lumens during embolization
- Hypervascular Tumor Embolization: Hydrogel-mediated embolization using HES filling tumor-feeding vessel lumens with a soft hydrogel to embolize hypervascular tumors during interventional radiology procedures
- Peripheral Arterial Bleed Embolization: Hydrogel-mediated embolization using HES forms a soft hydrogel that fills vessel lumens to embolize peripheral arterial bleeds in interventional radiology.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Instylla
Mirador Biomedical
HQ: United States
Website
- Description: Provider of medical devices that deliver physiological feedback during common procedures, including single-use pressure transducers for distinguishing veins and arteries in central venous catheter insertion, measuring compartment pressure, pleural manometry and pleural pressure monitoring in thoracentesis, measuring opening pressure in lumbar puncture, and Central Venous Pressure monitoring via VA Lock.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mirador Biomedical company profile →
Spacelabs Healthcare
HQ: United States
Website
- Description: Provider of medical equipment and services to hospitals, clinics, and physician offices, offering patient monitoring and connectivity solutions, diagnostic cardiology, clinical informatics for collecting, analyzing, and visualizing clinical data, supplies and accessories, and Sentinel 11, a cardiology data management system enhancing security and accessibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spacelabs Healthcare company profile →
CathVision
HQ: Denmark
Website
- Description: Provider of novel hardware, software and data science solutions to guide ablation therapy of cardiac arrhythmia, including the ECGenius System for high-fidelity, low-noise electrogram acquisition; CARDIALYTICS for automated electrogram interpretation; PVI Analyzer and Signal Complexity visualization tools; and FaST Mapping, an AI-based algorithm in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CathVision company profile →
BiO2 Medical
HQ: United States
Website
- Description: Provider of the Angel Catheter that provides prophylactic pulmonary embolism protection and access to the central venous system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BiO2 Medical company profile →
CVR Medical
HQ: Canada
Website
- Description: Provider of the Carotid Stenotic Scan (CSS), a diagnostic tool that detects and measures carotid artery narrowing to identify patients at risk for ischemic stroke using non-invasive sound wave analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CVR Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Instylla
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Instylla
2.2 - Growth funds investing in similar companies to Instylla
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Instylla
4.2 - Public trading comparable groups for Instylla
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →